Neuro-Oncology Reviews

Volume 26 Number 19
10 September 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 19, 10 September

Hutton DL, Burns TC, Hossain-Ibrahim K.
A review of sonodynamic therapy for brain tumors.
Neurosurg Focus. 2024 Sep 1;57(3):E7. doi: 10.3171/2024.6.FOCUS24338. PMID: 39217635. Review. ˍ

Huo X, Li H, Xing Y, Liu W, Chen P, Du F, Song L, Yu Z, Cao X, Tian J.
Two decades of progress in glioma methylation research: the rise of temozolomide resistance and immunotherapy insights.
Front Neurosci. 2024 Sep 2;18:1440756. doi: 10.3389/fnins.2024.1440756. PMID: 39286478. Bibliometric analysis. ˍ .

*Lerner A, Palmer K, Campion T, Millner TO, Scott E, Lorimer C, Paraskevopoulos D, McKenna G, Marino S, Lewis R, Plowman N.
Gliomas in adults: Guidance on Investigations, Diagnosis, Treatment & Surveillance.
Clin Med (Lond). 2024 Sep 2:100240. doi: 10.1016/j.clinme.2024.100240. PMID: 39233205. Review. ˍ

Ospina JP, Wen PY.
Medical and neurologic management of brain tumor patients.
Curr Opin Neurol. 2024 Sep 2;37(6):657-665. doi: 10.1097/WCO.0000000000001315. PMID: 39221926. Guidelines. ˍ

Feng F, Shen J, Qi Q, Zhang Y, Ni S.
Empowering brain tumor management: chimeric antigen receptor macrophage therapy.
Theranostics. 2024 Sep 3;14(14):5725-5742. doi: 10.7150/thno.98290. PMID: 39310093. Review. ˍ

Ospina JP, Wen PY.
Medical and neurologic management of brain tumor patients.
Curr Opin Neurol. 2024 Sep 3;37(6):657-665. doi: 10.1097/WCO.0000000000001315. PMID: 39221926. Recommendations. ˍ

Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H, Zhang X, Zhang S, Chen Q.
Targeting ferroptosis opens new avenues in gliomas.
Int J Biol Sci. 2024 Sep 3;20(12):4674-4690. doi: 10.7150/ijbs.96476. PMID: 39309434. Review. ˍ

Xu Q, Yang C, Wang L, Zhou J.
Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets.
Cell Signal. 2024 Sep 3;124:111380. doi: 10.1016/j.cellsig.2024.111380. PMID: 39236835. Review˰ ˍ

Mazzoleni A, Awuah WA, Sanker V, Bharadwaj HR, Aderinto N, Tan JK, Huang HYR, Poornaselvan J, Shah MH, Atallah O, Tawfik A, Elmanzalawi MEAE, Ghozlan SH, Abdul-Rahman T, Moyondafoluwa JA, Alexiou A, Papadakis M.
Chromosomal instability: a key driver in glioma pathogenesis and progression.
Eur J Med Res. 2024 Sep 4;29(1):451. doi: 10.1186/s40001-024-02043-8. PMID: 39227895. Review. ˍ

Oliver K, Granero A, Berankova A, Miller C, Hindson C, La Haye C, Tse C, Mungoshi C, Leach D, Arons D, Keegan F, Bulbeck H, Adams H, Dirksje Boer J, Wallgren K, Syed K, Hynes L, Gatellier L, Magiera M, Lim M, Campbell M, Willmarth N, Garg N, Riis Olsen P, Rogers S, Gupta T, Mitchell Skinner T, Moue Y.
Brain tumor patients' rights and the power of patient advocacy: The current international landscape.
Neurooncol Pract. 2024 Sep 4;12(1):5-18. doi: 10.1093/nop/npae079. PMID: 39917767. Review. ˍ ˍ

Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF, Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R, D'Amico RS.
Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04813-0. PMID: 39230804. Review˰ ˍ

Tao R, Han K, Wu SC, Friske JD, Roussel MF, Northcott PA.
Arrested development: the dysfunctional life history of medulloblastoma.
Genes Dev. 2024 Sep 4. doi: 10.1101/gad.351936.124. PMID: 39231614. Review. ˍ

*White AJ, Harary M, Casaos J, Everson RG.
Current immunotherapy techniques in meningioma.
Expert Rev Anticancer Ther. 2024 Sep 4:1-11. doi: 10.1080/14737140.2024.2399252. PMID: 39233324. Review˰ ˍ

Lotsch C, Warta R, Herold-Mende C.
The Molecular and Immunological Landscape of Meningiomas.
Int J Mol Sci. 2024 Sep 5;25(17):9631. doi: 10.3390/ijms25179631. PMID: 39273576. Review. ˍ

Tataranu LG, Turliuc S, Kamel A, Rizea RE, Dricu A, Staicu GA, Baloi SC, Rodriguez SMB, Manole AIM.
Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance.
Curr Issues Mol Biol. 2024 Sep 5;46(9):9881-9894. doi: 10.3390/cimb46090588. PMID: 39329940. Review. ˍ

*Yoel A, Adjumain S, Liang Y, Daniel P, Firestein R, Tsui V.
Emerging and Biological Concepts in Pediatric High-Grade Gliomas.
Cells. 2024 Sep 5;13(17):1492. doi: 10.3390/cells13171492. PMID: 39273062. Review. ˍ

Heming CP, Aran V.
The Potential of Circulating Cell-Free RNA in CNS Tumor Diagnosis and Monitoring: A Liquid Biopsy Approach.
Crit Rev Oncol Hematol. 2024 Sep 7:104504. doi: 10.1016/j.critrevonc.2024.104504. PMID: 39251048. Review˰ ˍ

Goliot N, Mohssine S, Stefan D, Leclerc A, Emery E, Riverain J, Missohou F, Geffrelot J, Kao W, Valable S, Balosso J, Lesueur P.
Proton therapy for adult-type diffuse glioma: a systematic review.
Crit Rev Oncol Hematol. 2024 Sep 7:104501. doi: 10.1016/j.critrevonc.2024.104501. PMID: 39251047. Review˰ ˍ

Paltin I, Sy M, Lundy SM, Ayr-Volta LK, Canale R, Fong G, Janke K, Pfeifle GB, Quinton T, Schofield HL, Warren EAH.
Neuropsychological Late Effects and Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role of Pediatric Neurologists in Monitoring and Management.
Pediatr Neurol. 2024 Sep 7;161:149-157. doi: 10.1016/j.pediatrneurol.2024.08.014. PMID: 39383589. Review˰ ˍ

Habibi MA, Mirjani MS, Ahmadvand MH, Delbari P, Arab S, Minaee P, Eazi S, Ahmadpour S.
The clinical utility of autologous tumor lysate-loaded dendritic cell vaccination for patients with glioma: A systematic review and meta-analysis.
Asia Pac J Clin Oncol. 2024 Sep 8. doi: 10.1111/ajco.14110. PMID: 39244742. Review. ˍ

He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B.
Radiogenomics: bridging the gap between imaging and genomics for precision oncology.
MedComm (2020). 2024 Sep 9;5(9):e722. doi: 10.1002/mco2.722. PMID: 39252824. Review. ˍ

Kumar A, Shukla R.
Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme.
J Biomater Sci Polym Ed. 2024 Sep 9:1-35. doi: 10.1080/09205063.2024.2396721. PMID: 39250527. Review˰ ˍ

Ronsley R, Bertrand KC, Song EZ, Timpanaro A, Choe M, Tlais D, Vitanza NA, Park JR.
CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials.
Cancer Metastasis Rev. 2024 Sep 9. doi: 10.1007/s10555-024-10208-4. PMID: 39251462. Review. ˍ

Xu E, Patterson J, Angione A, Li A, Wu DW, Akca E, Elghawy O, Barsouk A, Sussman JH.
Low-Grade Glioma Clinical Trials in the United States: A Systematic Review.
Life (Basel). 2024 Sep 9;14(9):1133. doi: 10.3390/life14091133. PMID: 39337916. Review. ˍ

Giuliani P, De Simone C, Febo G, Bellasame A, Tupone N, Di Virglio V, di Giuseppe F, Ciccarelli R, Di Iorio P, Angelucci S.
Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?
Int J Mol Sci. 2024 Sep 10;25(18):9778. doi: 10.3390/ijms25189778. PMID: 39337267. Review. ˍ

Keane L, Cryan JF, Gleeson JP.
Exploiting the gut microbiome for brain tumour treatment.
Trends Mol Med. 2024 Sep 10:S1471-4914(24)00222-3. doi: 10.1016/j.molmed.2024.08.008. PMID: 39256110. Review. ˍ

Zuo M, Li T, Wang Z, Xiang Y, Chen S, Liu Y.
Research progress on platelets in glioma.
Chin Med J (Engl). 2024 Sep 10. doi: 10.1097/CM9.0000000000003282. PMID: 39252160. Review. ˍ